Medication info
Ostol Plus Tablet

Ostol Plus Tablet

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
Light orange oval film-coated tablet
Packaging
4 tablets/box [4 tablets/PTP x 1]
Approval status
Active

MFDS item code 201604693 · Approved 2016.07.29 · Insurance code 657805880

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
Adults: Administer 1 tablet orally once weekly. Elderly patients: No dosage adjustment is necessary because the bioavailability and pharmacokinetics of this product in elderly patients (60 years of age and older) are similar to those in younger people. Patients with renal impairment: No dosage adjustment is necessary in patients with a creatinine clearance of 30ml/min or greater. This product is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30ml/min. Food interferes with the absorption of this product; therefore, to ensure adequate absorption, take it as follows. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To facilitate passage of this product into the stomach and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking this product with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this product because of the possibility of oropharyngeal ulceration. Patients should also remain upright for at least 30 minutes after taking it. If a patient's dietary intake of calcium and vitamin D is inadequate, supplements should be taken. Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, nursing home residents, and patients with chronic diseases) may require additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This product provides one week's supply of vitamin D at a daily dose of 800 IU when taken once weekly. If a patient forgets to take a dose on the scheduled day, take it on the day it is remembered. Take the next dose on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
Pediatric patients: Safety and efficacy in children and adolescents who are still growing have not been established.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

  • Osteoporosis
View approved original text

This medication is used for treating and preventing osteoporosis in postmenopausal women and treating osteoporosis in men.

How to take

Adult dose

Adults: Administer 1 tablet orally once weekly. Elderly patients: No dosage adjustment is necessary because the bioavailability and pharmacokinetics of this product in elderly patients (60 years of age and older) are similar to those in younger people. Patients with renal impairment: No dosage adjustment is necessary in patients with a creatinine clearance of 30ml/min or greater. This product is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30ml/min. Food interferes with the absorption of this product; therefore, to ensure adequate absorption, take it as follows. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To facilitate passage of this product into the stomach and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking this product with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this product because of the possibility of oropharyngeal ulceration. Patients should also remain upright for at least 30 minutes after taking it. If a patient's dietary intake of calcium and vitamin D is inadequate, supplements should be taken. Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, nursing home residents, and patients with chronic diseases) may require additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This product provides one week's supply of vitamin D at a daily dose of 800 IU when taken once weekly. If a patient forgets to take a dose on the scheduled day, take it on the day it is remembered. Take the next dose on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

Pediatric patients: Safety and efficacy in children and adolescents who are still growing have not been established.

Precautions

This medication may irritate the gastric mucosa and cause esophageal problems such as esophagitis or esophageal ulcers. Therefore, it should be taken with sufficient water, and one should avoid lying down for some time after taking it. If there is pain or discomfort in the esophagus, discontinue use immediately and consult a physician. This medication should not be administered to patients with certain conditions, such as those with esophageal motility disorders or severe renal impairment. Additionally, patients with a known allergy to this medication or genetic issues like lactose intolerance should also avoid taking it. While taking this medication, various side effects such as indigestion, abdominal pain, myalgia, arthralgia, headache, dizziness, and skin rash may occur. If any unusual symptoms arise, they should inform the healthcare professionals. Calcium and vitamin D intake is crucial while using this medication, and it is advisable for osteoporosis patients to supplement both calcium and vitamin D. It is also important to note that taking this medication with food or drinks containing divalent cations such as calcium, magnesium, and iron may interfere with absorption. Use of this medication during pregnancy or breastfeeding should be approached with caution, and consulting a physician is recommended if necessary. As safety and efficacy in pediatric patients have not been established, it is generally recommended not to administer this medication to children. In case of overdose, hypocalcemia may occur, so immediate medical assistance should be sought for appropriate treatment. Keep this medication out of reach of children, and do not transfer it to another container for safety.

Side effects

esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, bleeding, gastric ulcer, duodenitis, glossitis, decreased serum calcium, decreased serum phosphorus, infection, low back pain, pain, abdominal pain, pain in the neck region, weakness, chest pain, hernia, hypertension, cardiovascular disease, angina, nausea, diarrhea, bloating, gastritis, gastrointestinal disease, rectal disease, dental disease, petechiae, anemia, arthralgia, joint abnormalities, myalgia, bone pain, bone abnormalities, leg cramps, bursitis, tendon abnormalities, depression, dizziness, insomnia, anxiety, neuralgia, vertigo, tension increase, sensory abnormalities, pharyngitis, rhinitis, dyspnea, pneumonia, rash, itching, skin cancer, cataract, conjunctivitis, otitis media, urinary tract infection, cystitis, injuries from accidents, epidemic cold syndrome, headache, overdose, allergic reaction, syncope, vasodilation, constipation, dyspepsia, nausea, gastroenteritis, colitis, vomiting, thirst, peripheral edema, traumatic fracture, myopathy, arthritis, bronchitis, sinusitis, increased cough, facial swelling, hair loss, altered sense of smell, Stevens-Johnson syndrome, toxic epidermal necrolysis, angioedema, blisters, jawbone necrosis, liver function impairment, jaundice, osteonecrosis of the external auditory canal, loss of appetite, discomfort in the chest, palpitations, increased sweating, facial flushing, burning sensation, kidney stones, belching, hematuria, fever

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container as it may be sensitive to air and moisture. Additionally, avoid storing it in excessively hot or cold places, and it is advisable to keep it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Light orange oval film-coated tablet

Package unit

4 tablets/box [4 tablets/PTP x 1]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.